| pubmed-article:134818 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0015780 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0029965 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0334024 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0733758 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0439659 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0695347 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C0392762 | lld:lifeskim |
| pubmed-article:134818 | lifeskim:mentions | umls-concept:C1511572 | lld:lifeskim |
| pubmed-article:134818 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:134818 | pubmed:dateCreated | 1976-11-21 | lld:pubmed |
| pubmed-article:134818 | pubmed:abstractText | Female Wistar rats were injected with two successive doses of 150 mug FSH on dioestrus I (5 p. m.) and dioestrus II (9 a.m.) of 4-day cycles. Superovulation and formation of an increased number of corpora lutea with included oocytes occurred in these animals. Meprobamate or pentobarbitone injections at 11.30 a.m. et 1.30 p.m. respectively completely blocked ovulation and luteinization phenomena in FSH-treated females. Ovulation normally occurred in FSH-treated females injected with meprobamate at 5.30 p.m. It was concluded that no modification of timing of the 'critical period' resulted from FSH treatment. | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:language | fre | lld:pubmed |
| pubmed-article:134818 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:134818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:134818 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:134818 | pubmed:issn | 0037-9026 | lld:pubmed |
| pubmed-article:134818 | pubmed:author | pubmed-author:GeigerJ MJM | lld:pubmed |
| pubmed-article:134818 | pubmed:author | pubmed-author:ChateauDD | lld:pubmed |
| pubmed-article:134818 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:134818 | pubmed:volume | 170 | lld:pubmed |
| pubmed-article:134818 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:134818 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:134818 | pubmed:pagination | 464-8 | lld:pubmed |
| pubmed-article:134818 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:134818 | pubmed:otherAbstract | PIP: 158 female rats, aged 3-4 months, weighing an average of 210 gm were administered 2 successive doses of 150 mcg of follicle stimulating hormone (FSH) on Diestrous 1 (5 p.m.) and Diestrous 2 (9 a.m.) of 4-day cycles. Superovulation and the formation of an increased number of corpora lutea with oocytes was observed. The administration of injections of meprobamate or pentobarbitone at 11:30 a.m. and 1:30 p.m., respectively, completely blocked ovulation and luteinization in these animals. Ovulation normally occurred in those FSH-treated females who were administered meprobamate at 5:30 p.m. These results were observed in 70% of the test animals. It is concluded that no modification of timing of the critical period resulted from the FSH treatment. | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-A... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-C... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-P... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-O... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-F... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-R... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-E... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-F... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-P... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-M... | lld:pubmed |
| pubmed-article:134818 | pubmed:meshHeading | pubmed-meshheading:134818-C... | lld:pubmed |
| pubmed-article:134818 | pubmed:year | 1976 | lld:pubmed |
| pubmed-article:134818 | pubmed:articleTitle | [Chronologic and quantitative modalities of luteinization and ovulation in the female rat exposed to FSH action at the beginning of 4-day cycles]. | lld:pubmed |
| pubmed-article:134818 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:134818 | pubmed:publicationType | English Abstract | lld:pubmed |
